EISSN 2148-5607

TJG is categorized as Q3 in JIF. TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.6

Turkish Journal of Gastroenterology

36 433 2025

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

Correlation Between Kidney Function and Intestinal Biological Characteristics of Adenine and Folium SennaeInduced Diarrhea Model in Mice

Xiaoya Li, Jiayuan Zhu, Yi Wu, Zhoujin Tan

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives

Bernel et al.

Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?

Kantarcıoğlu et al.

Epigenetics of Inflammatory Bowel Diseases

Törüner and Ünal

Vonoprazan on the Eradication of Helicobacter pylori Infection

Huang and Lin

Acute Pancreatitis Review

Huang and Badurdeen

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

The level of antithrombin III in cases with primer hepatocellular cancer

Yüksel GÖKGEL ¹ , Gürsel ÖZGÜR ² , Salih Ö. ÇOLAKOĞLU ² , Birol Soner KOLTAŞ ³ , Hikmet AKKIZ ²

Author Affiliation(s)

1.

Çukurova Üniversitesi Tıp Fakültesi Gastroenteroloji Anabilim Dalları, Adana

2.

Çukurova Üniversitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı, Adana

3.

Çukurova Üniversitesi Tıp Fakültesi Gastroenteroloji ve Biyokimya Anabilim Dalları, Adana

Turk J Gastroenterol 1996; 7: 295-297

Keywords : hiperkoagülabilite, primer hepatocellular cancer, antithrombin III, cirrhosis, metastatic liver cancer, hypercoagulability.

Read: 1567 Published: 25 July 2019

Volume 7, Issue 4, December 1996

Previous Article